Viewing Study NCT00312767


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-04-09 @ 3:25 AM
Study NCT ID: NCT00312767
Status: WITHDRAWN
Last Update Posted: 2014-02-05
First Post: 2006-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.
Sponsor: Genzyme, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fabry Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Agalsidase beta View
None alpha Galactosidase A View
None aGAL View
None rh aGAL View
None Fabry View
None GL3 View
None Fabrazyme View
None dialysis View
None hemodialysis View